Authors:
BELJAARDS RC
VANBEEK P
NIEBOER C
STOOF TJ
BOORSMA DM
Citation: Rc. Beljaards et al., THE EXPRESSION OF INTERLEUKIN-8 RECEPTOR IN UNTREATED AND TREATED PSORIASIS, Archives of dermatological research, 289(8), 1997, pp. 440-443
Citation: Rc. Beljaards et al., RELATION BETWEEN EXPRESSION OF ADHESION MOLECULES AND CLINICAL BEHAVIOR IN CUTANEOUS FOLLICLE CENTER CELL LYMPHOMAS, Journal of the American Academy of Dermatology, 37(1), 1997, pp. 34-40
Authors:
JASPARS LH
BELJAARDS RC
BONNET P
WILLEMZE R
MEIJER CJLM
Citation: Lh. Jaspars et al., DISTINCTIVE ADHESION PATHWAYS ARE INVOLVED IN EPITHELIOTROPIC PROCESSES AT DIFFERENT SITES, Journal of pathology, 178(4), 1996, pp. 385-392
Authors:
GEELEN FAMJ
BELJAARDS RC
VANDERPUTTE SCJ
KLUIN P
WILLEMZE R
Citation: Famj. Geelen et al., DIFFERENCES IN THE EXPRESSION OF BCL-2 PROTEIN AND ADHESION MOLECULESBETWEEN PROGNOSTICALLY DIFFERENT GROUPS OF PRIMARY CUTANEOUS LARGE B-CELL LYMPHOMAS, Journal of investigative dermatology, 107(3), 1996, pp. 315-315
Authors:
ZONNEVELD IM
DERIE MA
BELJAARDS RC
VANDERRHEE HJ
WUITE J
ZEEGELAAR J
BOS JD
Citation: Im. Zonneveld et al., THE LONG-TERM SAFETY AND EFFICACY OF CYCLOSPORINE IN SEVERE REFRACTORY ATOPIC-DERMATITIS - A COMPARISON OF 2 DOSAGE REGIMENS, British journal of dermatology, 135, 1996, pp. 15-20
Authors:
BELJAARDS RC
MEIJER CJLM
VANDERPUTTE CJ
HOLLEMA H
GEERTS ML
BEZEMER PD
WILLEMZE R
Citation: Rc. Beljaards et al., PRIMARY CUTANEOUS T-CELL LYMPHOMA - CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC PARAMETERS OF 35 CASES OTHER THAN MYCOSIS-FUNGOIDES AND CD30-POSITIVE LARGE-CELL LYMPHOMA, Journal of pathology, 172(1), 1994, pp. 53-60
Authors:
DEBRUIN PC
BELJAARDS RC
VANHEERDE P
VANDERVALK P
NOORDUYN LA
VANKRIEKEN JHJM
KLUINNELEMANS JC
WILLEMZE R
MEIJER CJLM
Citation: Pc. Debruin et al., DIFFERENCES IN CLINICAL BEHAVIOR AND IMMUNOPHENOTYPE BETWEEN PRIMARY CUTANEOUS AND PRIMARY NODAL ANAPLASTIC LARGE-CELL LYMPHOMA OF T-CELL OR NULL-CELL PHENOTYPE, Histopathology, 23(2), 1993, pp. 127-135
Citation: R. Willemze et Rc. Beljaards, SPECTRUM OF PRIMARY CUTANEOUS CD30 (KI-1)-POSITIVE LYMPHOPROLIFERATIVE DISORDERS - A PROPOSAL FOR CLASSIFICATION AND GUIDELINES FOR MANAGEMENT AND TREATMENT, Journal of the American Academy of Dermatology, 28(6), 1993, pp. 973-980